Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer
Clinical trial NCT06394661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06394661
- Sponsor
- Henan Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-28
- Primary completion
- 2025-12-30
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.